Honrao, C., Ma, X., Kulkarni, S., Joshi, V., Malamas, M., Zvonok, A., . . . Makriyannis, A. (2021). Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite. Frontiers in pharmacology, 12, 630274. https://doi.org/10.3389/fphar.2021.630274
Citace podle Chicago (17th ed.)Honrao, Chandrashekhar, et al. "Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite." Frontiers in Pharmacology 12 (2021): 630274. https://doi.org/10.3389/fphar.2021.630274.
Citace podle MLA (9th ed.)Honrao, Chandrashekhar, et al. "Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite." Frontiers in Pharmacology, vol. 12, 2021, p. 630274, https://doi.org/10.3389/fphar.2021.630274.